Dec 15, 2025 · The Galleri test is a multi-cancer early detection (MCED) blood test that screens for cancers before they become symptomatic, including those we don’t have recommended …

Multi-cancer detection (MCD) tests like the GRAIL Galleri test have the potential to find more than one type of cancer from a single sample of blood. Learn more here.

Feb 13, 2025 · A patient with a positive GRAIL test result has about a 55% chance of having a false positive and a 45% chance of having cancer. A positive result should be followed up …

Dec 27, 2025 · GRAIL, Inc. has reported positive test results for the Galleri cancer screening blood test.

Learn how to request Galleri, a screening test that looks for cancer before symptoms appear, when cancer may be easier to treat.

Dec 26, 2025 · If Grail’s MCED test is approved by the FDA, it could fundamentally change the way clinicians approach cancer screenings. There are more than 200 types of cancer, 70% of …

The Grail Multi-Cancer Test excels in its ability to detect multiple cancer types with remarkable accuracy. Rather than relying solely on traditional methods, which often focus on a single type …

Oct 20, 2025 · Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s detailing its latest data as it heads to the FDA.

The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer …

2 days ago · Mercy is participating in a study designed to evaluate the clinical impact of GRAIL’s Galleri® multi-cancer early detection (MCED) test among Medicare beneficiaries. The three …